954 related articles for article (PubMed ID: 1700619)
21. Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth.
Merz H; Fliedner A; Orscheschek K; Binder T; Sebald W; Müller-Hermelink HK; Feller AC
Am J Pathol; 1991 Nov; 139(5):1173-80. PubMed ID: 1951632
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
Ho CL; Sheu LF; Li CY
Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture.
Petzelbauer P; Bender JR; Wilson J; Pober JS
J Immunol; 1993 Nov; 151(9):5062-72. PubMed ID: 7691964
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections.
Rowlands DC; Hansel TT; Crocker J
J Pathol; 1990 Mar; 160(3):239-43. PubMed ID: 2139890
[TBL] [Abstract][Full Text] [Related]
25. Increased levels of circulating cytokines in patients with untreated Hodgkin's disease.
Gause A; Keymis S; Scholz R; Schobert I; Jung W; Diehl V; Pohl C; Pfreundschuh M
Lymphokine Cytokine Res; 1992 Apr; 11(2):109-13. PubMed ID: 1581417
[TBL] [Abstract][Full Text] [Related]
26. Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndrome.
De Vita S; Dolcetti R; Ferraccioli G; Pivetta B; De Re V; Gloghini A; D'Agosto A; Bartoli E; Carbone A; Boiocchi M
J Rheumatol; 1995 Sep; 22(9):1674-80. PubMed ID: 8523344
[TBL] [Abstract][Full Text] [Related]
27. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
Hsu SM; Xie SS; Hsu PL; Waldron JA
Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
[TBL] [Abstract][Full Text] [Related]
29. LPS and cytokine-induced endothelial cell IL-6 release and ELAM-1 expression; involvement of serum.
von Asmuth EJ; Leeuwenberg JF; Ceska M; Buurman WA
Eur Cytokine Netw; 1991; 2(4):291-7. PubMed ID: 1721850
[TBL] [Abstract][Full Text] [Related]
30. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes.
Batten P; Yacoub MH; Rose ML
Immunology; 1996 Jan; 87(1):127-33. PubMed ID: 8666424
[TBL] [Abstract][Full Text] [Related]
31. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease.
Kadin ME; Muramoto L; Said J
Am J Pathol; 1988 Feb; 130(2):345-53. PubMed ID: 2963547
[TBL] [Abstract][Full Text] [Related]
32. IL-4 and IL-13 downregulate rolling adhesion of leukocytes to IL-1 or TNF-alpha-activated endothelial cells by limiting the interval of E-selectin expression.
Etter H; Althaus R; Eugster HP; Santamaria-Babi LF; Weber L; Moser R
Cytokine; 1998 Jun; 10(6):395-403. PubMed ID: 9632524
[TBL] [Abstract][Full Text] [Related]
33. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
[TBL] [Abstract][Full Text] [Related]
34. The patterns of IL2, IFN-gamma, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar.
Serrano D; Ghiotto F; Roncella S; Airoldi I; Cutrona G; Truini M; Burgio VL; Baroni CD; Ferrarini M; Pistoia V
Haematologica; 1997; 82(5):542-9. PubMed ID: 9407718
[TBL] [Abstract][Full Text] [Related]
35. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
36. VCAM-1 is not involved in LPAM-1 (alpha 4 beta p/alpha 4 beta 7) mediated binding of lymphoma cells to high endothelial venules of mucosa-associated lymph nodes.
Hahne M; Lenter M; Jäger U; Isenmann S; Vestweber D
Eur J Cell Biol; 1993 Aug; 61(2):290-8. PubMed ID: 7693472
[TBL] [Abstract][Full Text] [Related]
37. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.
Tesch H; Günther A; Abts H; Jücker M; Klein S; Krueger GR; Diehl V
Am J Pathol; 1993 Jun; 142(6):1714-20. PubMed ID: 8506943
[TBL] [Abstract][Full Text] [Related]
38. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
39. BLA.36: a glycoprotein specifically expressed on the surface of Hodgkin's and B cells.
Imam A; Stathopoulos E; Taylor CR
Anticancer Res; 1990; 10(4):1095-104. PubMed ID: 1696446
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
